DocGo Reports Q3 Revenue of $70.8 Million

Reuters
Nov 11
DocGo Reports Q3 Revenue of $70.8 Million

DocGo Inc. reported total revenue of $70.8 million for the third quarter of 2025, down from $138.7 million in the same period of 2024. The decrease was attributed to the wind-down of migrant-related programs, which contributed $8.4 million in revenue for the third quarter of 2025 compared to $80.7 million in the prior year. Excluding migrant-related programs, revenue increased 8% to $62.4 million from $58.0 million in the third quarter of 2024. The company noted record volumes across its core mobile health and medical transportation businesses. Management stated that each service line, except for care gap closure and primary care offerings, was adjusted EBITDA positive on a contribution basis. DocGo issued 2026 guidance projecting a base business revenue increase of 12% to 20%, based on already contracted revenues, and expects to exit 2026 with an adjusted EBITDA positive run rate at the top end of the range.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DocGo Inc. published the original content used to generate this news brief on November 10, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10